360 Obesity Summit 2025: A Collaborative Approach to Weight Management

5th November 2025, Singapore – Neoasia proudly hosted the 360 Obesity Summit, an insightful event dedicated to advancing holistic solutions for obesity management through innovation and collaboration. This summit marked a significant partnership between Neoasia and Novo Nordisk, reinforcing a shared commitment to improving patient outcomes in the Asia-Pacific region.

The event featured two esteemed speakers:

• Dr Youngwook Ko delivered an engaging presentation on ONDA Pro, a cutting-edge non-invasive body contouring technology designed to reduce stubborn fat and improve skin laxity, offering patients a safe and effective solution for body sculpting.
• Dr Bazz shared expert insights on Wegovy, a breakthrough GLP-1 receptor agonist therapy for chronic weight management, highlighting its clinical efficacy and role in supporting sustainable lifestyle changes.

The 360 Obesity Summit provided a platform for healthcare professionals to explore integrated approaches combining advanced medical devices and pharmacological therapies, paving the way for comprehensive obesity care.

Neoasia remains committed to fostering partnerships and knowledge exchange that empower practitioners to deliver transformative results for patients across the region.